Idiopathic pulmonary fibrosis (IPF) is characterized by a progressive decline in lung function, worsening quality of life, and high mortality. However, the rate and pattern of progression of IPF ...
In a recent study published in Nature Metabolism, researchers investigated the association between cellular ... in mice with lung fibrosis and people with idiopathic pulmonary fibrosis (IPF).
The aging and failure of cells that occurs when the liver is damaged can spread to other organs, suggests a new study in mice ...
The term “progressive pulmonary fibrosis” or “PPF” is generally used to describe progressive lung fibrosis in an individual with an interstitial lung disease (ILD) other than idiopathic ...
The topline data showed ISM001-055 to have improved the forced vital capacity (FVC) of IPF patients studied 12 weeks after ...
In a small Phase IIa trial, Insilico’s generative AI-designed idiopathic pulmonary fibrosis drug improved lung function and ...
Insilico Medicine plans to push its computer-designed drug into pivotal clinical trials after a phase 2a study demonstrated ...
The UAB ILD Center offers clinical trial enrollment for patients with idiopathic pulmonary fibrosis and other forms of diffuse parenchymal lung disease as part of a multidisciplinary and integrated ...
News Medical on MSN1mon
Researchers uncover how senescent cells can both harm and heal in liver diseaseNew genetic tools reveal the dual roles of senescent cells in liver disease—macrophages drive fibrosis ... and manipulate ...
The UAB ILD Center offers clinical trial enrollment for patients with idiopathic pulmonary fibrosis and other forms of diffuse parenchymal lung disease as part of a multidisciplinary and integrated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback